BioAdaptives Inc. Increase (Decrease) in Derivative Assets and Liabilities
BioAdaptives Inc. (BDPT) reported Increase (Decrease) in Derivative Assets and Liabilities of $162.75 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities · last filed 2022-05-12
- BioAdaptives Inc. increase (decrease) in derivative assets and liabilities for the quarter ending 2022-03-31 was $162.75K, a 3.37% decline year-over-year.
- BioAdaptives Inc. increase (decrease) in derivative assets and liabilities for the quarter ending 2021-12-31 was -$94.20K, a 198.09% decline year-over-year.
- BioAdaptives Inc. increase (decrease) in derivative assets and liabilities for the quarter ending 2021-09-30 was -$203.30K.
- BioAdaptives Inc. increase (decrease) in derivative assets and liabilities for the quarter ending 2021-06-30 was $219.29K, a 39.91% decline year-over-year.
- BioAdaptives Inc. increase (decrease) in derivative assets and liabilities for fiscal 2021 was $90.22K, a 75.10% decline from fiscal 2020.
- BioAdaptives Inc. increase (decrease) in derivative assets and liabilities for fiscal 2020 was $362.26K.
- BioAdaptives Inc. increase (decrease) in derivative assets and liabilities for fiscal 2019 was -$198.01K.
| Period end | Increase (Decrease) in Derivative Assets and Liabilities 3 month | Increase (Decrease) in Derivative Assets and Liabilities 6 month | Increase (Decrease) in Derivative Assets and Liabilities 9 month | Increase (Decrease) in Derivative Assets and Liabilities 12 month |
|---|---|---|---|---|
| 2022-03-31 | $162.75K 10-Q · filed 2022-05-12 | $68.55K derived: sum of 2 quarters · filed 2022-05-12 | -$134.75K derived: sum of 3 quarters · filed 2022-05-12 | $84.55K derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | -$94.20K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$297.50K derived: sum of 2 quarters · filed 2022-03-31 | -$78.21K derived: sum of 3 quarters · filed 2022-03-31 | $90.22K 10-K · filed 2022-03-31 |
| 2021-09-30 | -$203.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $15.99K derived: sum of 2 quarters · filed 2021-11-10 | $184.42K 10-Q · filed 2021-11-10 | $280.46K derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-06-30 | $219.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $387.72K 10-Q · filed 2021-08-12 | $483.76K derived: sum of 3 quarters · filed 2022-05-12 | $339.68K derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-03-31 | $168.43K 10-Q · filed 2022-05-12 | $264.47K derived: sum of 2 quarters · filed 2022-05-12 | $120.39K derived: sum of 3 quarters · filed 2022-05-12 | $485.32K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $96.04K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$48.04K derived: sum of 2 quarters · filed 2022-03-31 | $316.89K derived: sum of 3 quarters · filed 2022-03-31 | $362.26K 10-K · filed 2022-03-31 |
| 2020-09-30 | -$144.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $220.85K derived: sum of 2 quarters · filed 2021-11-10 | $266.22K 10-Q · filed 2021-11-10 | $223.29K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $364.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $410.30K 10-Q · filed 2021-08-12 | $367.37K derived: sum of 3 quarters · filed 2021-08-12 | $328.46K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $45.37K 10-Q · filed 2021-05-14 | $2.44K derived: sum of 2 quarters · filed 2021-05-14 | -$36.47K derived: sum of 3 quarters · filed 2021-05-14 | |
| 2019-12-31 | -$42.93K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$81.84K derived: sum of 2 quarters · filed 2021-03-30 | -$198.01K 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$38.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$155.08K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | -$116.17K 10-Q · filed 2020-08-13 |